Table 2. Prevalence of Hyperlactatemia and Lactic Acidosis in Patients with Type 2 Diabetes According to Metformin Use.
| Stratification by eGFR | Total, n (%) | No metformin use, n (%) | Metformin use, n (%) | p value |
|---|---|---|---|---|
| Total | 1954 | 754 | 1200 | |
| Hyperlactatemia | 368 (18.8) | 141 (18.7) | 227 (18.9) | 0.905 |
| Lactic acidosis | 58 (3.0) | 25 (3.3) | 33 (2.8) | 0.544 |
| eGFR ≥60 mL/min/1.73 m2 | 1438 | 0584 | 0854 | |
| Hyperlactatemia | 225 (15.6) | 93 (15.9) | 132 (15.5) | 0.810 |
| Lactic acidosis | 22 (1.5) | 12 (2.1) | 10 (1.2) | 0.180 |
| eGFR <60 mL/min/1.73 m2 | 516 | 170 | 346 | |
| Hyperlactatemia | 143 (27.7) | 48 (28.2) | 95 (27.5) | 0.853 |
| Lactic acidosis | 36 (7.0) | 13 (7.6) | 23 (6.9) | 0.769 |
eGFR, estimated glomerular filtration rate.